Paper23314745
Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.
Domagalski K and 7 others. Eur J Clin Microbiol Infect Dis, 2013. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4. Papers, record 23314745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23314745
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genotype | Major topic |
| Hepacivirus | Major topic |
| Hepatitis C, Chronic | Major topic |
| Interferon-alpha | Major topic |
| Interleukins | Major topic |
| Polyethylene Glycols | Major topic |
| Polymorphism, Single Nucleotide | Major topic |
| Ribavirin | Major topic |
| Adolescent | |
| Antiviral Agents | |
| Child | |
| Child, Preschool | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Interferons | |
| Male | |
| Recombinant Proteins | |
| Treatment Outcome | |
| Viral Load | |
| Interferon Lambda |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20136589 | Treatment of hepatitis C in children. | Expert Rev Gastroenterol Hepatol | 2010 | https://conductscience.org/library/papers/20136589 | PubMed |
| 2 | 22013729 | Pediatric hepatitis C infection: to treat or not to treat...what's the best for the child? | Eur Rev Med Pharmacol Sci | 2011 | https://conductscience.org/library/papers/22013729 | PubMed |
| 3 | 19904504 | Pegylated alpha interferon 2B plus ribavirin in the treatment of HCV genotype 4 infection. | Indian J Pediatr | 2009 | https://conductscience.org/library/papers/19904504 | PubMed |
| 4 | 19749758 | IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. | Nat Genet | 2009 | https://conductscience.org/library/papers/19749758 | PubMed |
| 5 | 20189674 | High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin. | J Hepatol | 2010 | https://conductscience.org/library/papers/20189674 | PubMed |
| 6 | 20728570 | Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C. | Clin Gastroenterol Hepatol | 2011 | https://conductscience.org/library/papers/20728570 | PubMed |
| 7 | 19840256 | Current issues in the management of paediatric viral hepatitis. | Liver Int | 2010 | https://conductscience.org/library/papers/19840256 | PubMed |
| 8 | 18925643 | Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors. | Hepatology | 2008 | https://conductscience.org/library/papers/18925643 | PubMed |
| 9 | 20060832 | Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. | Gastroenterology | 2010 | https://conductscience.org/library/papers/20060832 | PubMed |
| 10 | 20176026 | Replicated association between an IL28B gene variant and a sustained response to pegylated interferon and ribavirin. | Gastroenterology | 2010 | https://conductscience.org/library/papers/20176026 | PubMed |
| 11 | 19749757 | Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. | Nat Genet | 2009 | https://conductscience.org/library/papers/19749757 | PubMed |
| 12 | 18174875 | Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection. | Pediatr Infect Dis J | 2008 | https://conductscience.org/library/papers/18174875 | PubMed |
| 13 | 19756352 | Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C. | J Gastroenterol | 2009 | https://conductscience.org/library/papers/19756352 | PubMed |
| 14 | 18715665 | Treatment predictors of a sustained virologic response in hepatitis B and C. | J Hepatol | 2008 | https://conductscience.org/library/papers/18715665 | PubMed |
| 15 | 21413051 | Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. | Hepatology | 2011 | https://conductscience.org/library/papers/21413051 | PubMed |
| 16 | 19684573 | Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. | Nature | 2009 | https://conductscience.org/library/papers/19684573 | PubMed |
| 17 | 20633102 | Hepatitis C: viral and host factors associated with non-response to pegylated interferon plus ribavirin. | Liver Int | 2010 | https://conductscience.org/library/papers/20633102 | PubMed |
| 18 | 20526008 | Pegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents. | Ann Hepatol | 2010 | https://conductscience.org/library/papers/20526008 | PubMed |
| 19 | 15793840 | Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. | Hepatology | 2005 | https://conductscience.org/library/papers/15793840 | PubMed |
| 20 | 19625712 | Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19625712 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30987134 | Hepatitis C Virus Genetic Variability, Human Immune Response, and Genome Polymorphisms: Which Is the Interplay? | Cells | 2019 | https://conductscience.org/library/papers/30987134 | PubMed |
| 29238510 | Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection. | Electron Physician | 2017 | https://conductscience.org/library/papers/29238510 | PubMed |
| 28507928 | The Role of Direct-acting Antivirals in the Treatment of Children with Chronic Hepatitis C. | J Clin Transl Hepatol | 2017 | https://conductscience.org/library/papers/28507928 | PubMed |
| 28502443 | Hepatitis B and C. | Pediatr Clin North Am | 2017 | https://conductscience.org/library/papers/28502443 | PubMed |
| 26640716 | Serum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response? | Int J Hepatol | 2015 | https://conductscience.org/library/papers/26640716 | PubMed |
| 26478670 | What's new in hepatitis C virus infections in children? | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/26478670 | PubMed |
| 25473150 | New treatments for chronic hepatitis C: an overview for paediatricians. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25473150 | PubMed |
| 25071317 | Polymorphisms in the IFNL3/IL28B gene and hepatitis C: from adults to children. | World J Gastroenterol | 2014 | https://conductscience.org/library/papers/25071317 | PubMed |
| 24348648 | Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4. | Hepat Mon | 2013 | https://conductscience.org/library/papers/24348648 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNL3 | 282617 | PubTator's text mining | https://conductscience.org/library/genes/282617 | NCBI Gene |
| LOC102724197 | 102724197 | PubTator's text mining | https://conductscience.org/library/genes/102724197 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23314745
GET https://conductscience.org/api/papers/v1/23314745/references?page=2